NCT05569226View on ClinicalTrials.gov

OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Age-Related Macular Degeneration
Trial Locations (1)

Unknown

RECRUITING

Bristol, Bristol

Sponsors

Lead Sponsor

OKKO Health
All Listed Sponsors
lead

OKKO Health

INDUSTRY

NCT05569226 - OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter